InvestorsHub Logo
Followers 253
Posts 17905
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Thursday, 04/04/2024 3:47:37 PM

Thursday, April 04, 2024 3:47:37 PM

Post# of 423961
Amarin needs to increase the number of patients in the U.S. and the rest of world who are prescribed Vascepa to reduce risks from CVDs.

This week PLTR/ORCL and CDIO/Navierre have established a pair of separate collaborations that are designed to make AI-driven diagnostic algorithms for detecting patient risks of CVDs available to those patients who live in less-populated rural areas. Potential patients( e.g., those in wheelchairs that may have such risks) simply have not been driven/travelled to urban areas of USA to obtain the use of trained cardiology clinicians and complex/expensive imaging devices. We have seen here that trained cardiologists do/will prescribe Vascepa by email to pharmacies in urban areas for patients or caregivers to pickup.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News